ACE Report Cover
IA injection of morphine + bupivacaine vs. morphine alone for analgesia after arthroscopy
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
Sprache
Download Download Download
Herunterladen
Cite this Report Cite this Report Cite this Report
Zitieren
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ Favoriten
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
Sprache
Download Download Download
Herunterladen
Cite this Report Cite this Report Cite this Report
Zitieren
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ Favoriten
SPORTS MEDICINE
IA injection of morphine + bupivacaine vs. morphine alone for analgesia after arthroscopy .

OrthoEvidence Journal (OE Journal) - ACE Report

OE Journal. 2016;4(2):31 PLoS One. 2015 Oct 16;10(10):e0140512

13 randomized controlled trials were included in this systematic review and meta-analysis to determine the safety and efficacy of a single intra-articular injection of morphine + bupivacaine compared to morphine alone in managing pain after knee arthroscopy. Pooled analysis found combined treatment to significantly lower pain in the immediate postoperative period (0-2 hours) and significantly increase the time to first request for rescue analgesia compared to morphine alone. No significant differences in pain intensity from 2-48 hours or in the number of patients requiring rescue analgesia was observed between groups. Qualitative analysis found adverse events to be similar between treatment groups.


Details zur Finanzierung der Veröffentlichung +
Finanzierung:
Non-Industry funded
Sponsor:
The National Natural Science Foundation of China
Conflicts:
None disclosed

Risiko der Voreingenommenheit

9,5/10

Kriterien für die Berichterstattung

18/20

Fragilitäts-Index

N/A

Were the search methods used to find evidence (original research) on the primary question or questions stated?

Was the search for evidence reasonably comprehensive?

Were the criteria used for deciding which studies to include in the overview reported?

Was the bias in the selection of studies avoided?

Were the criteria used for assessing the validity of the included studies reported?

Was the validity of all of the studies referred to in the text assessed with use of appropriate criteria (either in selecting the studies for inclusion or in analyzing the studies that were cited)?

Were the methods used to combine the findings of the relevant studies (to reach a conclusion) reported?

Were the findings of the relevant studies combined appropriately relative to the primary question that the overview addresses?

Were the conclusions made by the author or authors supported by the data and or analysis reported in the overview?

How would you rate the scientific quality of this evidence?

Ja = 1

Ungewiss = 0.5

Nicht relevant = 0

Nein = 0

Die Bewertung der Berichtskriterien bewertet die Transparenz, mit der die Autoren die methodischen und studienspezifischen Merkmale der Studie in der Veröffentlichung angeben. Die Bewertung ist in fünf Kategorien unterteilt, die im Folgenden vorgestellt werden.

4/4

Introduction

4/4

Accessing Data

3/4

Analysing Data

4/4

Results

3/4

Discussion

Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbé KA. J Clin Epidemiol. 1992;45:255-65

Der Fragilitätsindex ist ein Instrument, das bei der Interpretation signifikanter Ergebnisse hilft und ein Maß für die Stärke eines Ergebnisses liefert. Der Fragilitätsindex gibt die Anzahl der aufeinanderfolgenden Ereignisse an, die zu einem dichotomen Ergebnis hinzugefügt werden müssen, damit das Ergebnis nicht mehr signifikant ist. Eine kleine Zahl steht für ein schwächeres Ergebnis und eine große Zahl für ein stärkeres Ergebnis.

Warum wurde diese Studie jetzt benötigt?

Knee arthroscopy is a procedure often accompanied by moderate-to-severe postoperative pain, making pain management an important consideration for patient recovery and decreased length of hospital stay. Intra-articular (IA) injections of local anaesthetic and analgesics have gained popularity given their practical application. Two common treatments with different mechanisms of action include morphine and bupivacaine. While both have proven effective in IA injection, their onset and duration of action vary. A combination of these two drugs may provide an earlier onset and longer duration of analgesia. However, previous studies have shown conflicting evidence regarding the efficacy of combination treatment over morphine alone, indicating a need for the present systematic review and meta-analysis.

Was war die wichtigste Forschungsfrage?

How safe and efficacious is a single-dose intra-articular injection of morphine plus bupivacaine in comparison to morphine alone in managing pain up to 48 hours after knee arthroscopy?

Merkmale der Studie +
Data Source:
An electronic database search was conducted using MEDLINE/PubMed, the Cochrane Central Register Trials (CENTRAL) and Embase, for English studies up to August 10, 2014. Reference lists of selected articles and recent reviews were additionally searched.
Index Terms:
Search terms included: "arthroscopy", "arthroscopic", "arthroscope", "anterior cruciate ligament", "bupivacaine", "morphine", "randomized controlled trial".
Study Selection:
Two independent reviewers assessed articles for adherence to inclusion criteria, and disagreements were resolved by consensus or judgement by a third reviewer. Inclusion criteria were randomized controlled trials (RCTs) on patients undergoing knee arthroscopy, with experimental groups receiving a combination of IA morphine and bupivacaine, control group receiving morphine only, and both groups not given other analgesics (13 RCT's [564 patients] included, 11 utilized in quantitative analysis).
Data Extraction:
Two independent reviewers extracted data using a standardized form. Postoperative pain intensity measured on a visual analogue scale (VAS) was the primary outcome. Secondary outcomes included time to first rescue medication, number of patients requiring supplementary analgesia, and adverse reactions.
Data Synthesis:
Review Manager 5.2 was used for meta-analyses. Continuous outcomes were reported as weighted mean difference (WMD) and dichotomous outcomes as relative risk (RR), both with corresponding 95% confidence intervals (CIs). Heterogeneity was assessed using the Q and I2 statistics with a p value>0.05 and an I2 > 50% indicating statistical heterogeneity. A random effects model was used in the case of significant heterogeneity, otherwise a fixed effect model was used for meta-analyses. Sensitivity analyses were conducted, publication bias was assessed using the Begg's test and funnel plots, and study quality was assessed by 2 independent reviewers using the Modified Oxford Scale.
Was waren die wichtigsten Ergebnisse?
  • During the immediate post-operative period (0-2h), the combined treatment group showed a significantly lower postoperative pain intensity compared with the morphine group (9 studies; 305 patients; WMD: -1.16 [95% CI -2.01, -0.31]; p=0.007; I2=82%)
  • During the early post-operative (2-6h) and late post-operative (6-48h) periods, no significant difference in pain intensity was observed between groups (Early: 8 studies; 237 patients; WMD: -0.36 [95% CI -1.13, 0.41]; p=0.35; I2=67% | Late: 8 studies; 257 patients; WMD: 0.32 [95% CI -0.32, 0.95]; p=0.33; I2=61%)
  • Time to first analgesic request was significantly greater in the combined treatment group compared with the morphine group (4 studies; 216 patients; WMD: 2.05 [95% CI 0.19, 3.92]; p=0.03; I2=95%)
  • No significant difference was observed between groups in the number of patients requiring supplementary analgesia (6 studies; 146 patients; RR: 0.78 [95% CI 0.57, 1.05]; p=0.10; I2=0%)
  • Sensitivity analyses confirmed all quantitative results except for difference in time to first analgesic request, which became insignificant between groups when studies that used epinephrine in the intervention treatment were removed (WMD: 2.20 [95% CI 0.01, 4.40]; p=0.05; I2=97%)
  • Adverse events were reported in 7 of 13 studies: 2 studies observed urinary retention, nausea and vomiting with no significant differences between groups, 4 studies found no adverse effects in either group
Was sollte ich mir besonders merken?

Following knee arthroscopy, a combined intra-articular injection of morphine and bupivacaine significantly lowered immediate (0-2 hours) postoperative pain intensity and increased time to first request for rescue analgesia compared to morphine alone. Sensitivity analysis removing studies which used epinephrine resulted in a nonsignificant between group difference in time to first analgesic request. No significant differences were observed between groups in terms of pain intensity during the early and late post-operative period (2-48 hours) or number of patients requiring rescue analgesia. Qualitative analysis found no significant difference in adverse events between groups.

Wie wird sich dies auf die Behandlung meiner Patienten auswirken?

Results suggest that for patients undergoing knee arthroscopy, administration of a single intra-articular injection of morphine plus bupivacaine provides better immediate pain relief and extended time until first analgesic request as compared to an injection of morphine alone, with no difference in adverse events. Further high-quality RCTs with homogeneous reporting methods and longer follow-up periods are required to effectively assess adverse events through pooled analysis.

HAFTUNGSAUSSCHLUSS

Der Inhalt dieser Seite dient nur zu Informationszwecken und ist nicht als Ersatz für professionelle medizinische Beratung, Diagnose oder Behandlung gedacht. Wenn Sie eine medizinische Behandlung benötigen, wenden Sie sich immer an Ihren Arzt oder suchen Sie die nächstgelegene Notaufnahme auf. Die Meinungen, Überzeugungen und Standpunkte, die von den Personen auf dieser Seite geäußert werden, spiegeln nicht die Meinungen, Überzeugungen und Standpunkte von OrthoEvidence wider.

0 von 4 monatliche KOSTENLOSE Artikel freigeschaltet
Sie haben Ihr Limit von 4 kostenlosen Artikeln in diesem Monat erreicht

Zugang zu OrthoEvidence für nur $1,99 pro Woche.

Bleiben Sie auf dem Laufenden mit den neuesten Beweisen. Jederzeit kündbar.
  • Kritische Beurteilungen der neuesten, hochwirksamen randomisierten kontrollierten Studien und systematischen Übersichten in der Orthopädie
  • Zugang zu OrthoEvidence-Podcast-Inhalten, einschließlich Kooperationen mit dem Journal of Bone and Joint Surgery, Interviews mit international anerkannten Chirurgen und Diskussionsrunden zu orthopädischen Neuigkeiten und Themen
  • Abonnement von The Pulse, einem zweimal wöchentlich erscheinenden evidenzbasierten Newsletter, der Ihnen helfen soll, bessere klinische Entscheidungen zu treffen
Upgrade
Willkommen zurück!
Passwort vergessen?
Starten Sie Ihre KOSTENLOSE Testversion noch heute!

Ihr Konto ist verbunden mit
und umfasst den kostenlosen Zugang zu OrthoEvidence


ODER
Passwort vergessen?

ODER
Bitte überprüfen Sie Ihre E-Mail

Wenn ein Konto mit der angegebenen E-Mail-Adresse existiert, wird Ihnen eine E-Mail zum Zurücksetzen des Passworts zugesandt. Wenn Sie keine E-Mail sehen, überprüfen Sie bitte Ihren Spam- oder Junk-Ordner.

Für weitere Hilfe, kontaktieren Sie unser Support-Team.

Bitte melden Sie sich an, um diese Funktion zu aktivieren

Um auf diese Funktion zugreifen zu können, müssen Sie bei einem aktiven OrthoEvidence-Konto angemeldet sein. Bitte melden Sie sich an oder erstellen Sie ein KOSTENLOSES Testkonto.

Übersetzen ACE Report

OrthoEvidence nutzt einen externen Übersetzungsdienst, um Inhalte in mehreren Sprachen zugänglich zu machen. Bitte beachten Sie, dass trotz aller Bemühungen um Genauigkeit die Übersetzungen nicht immer perfekt sind.

Wie man dies zitiert ACE Report

OrthoEvidence. IA injection of morphine + bupivacaine vs. morphine alone for analgesia after arthroscopy. OE Journal. 2016;4(2):31. Available from: https://myorthoevidence.com/AceReport/Show/ia-injection-of-morphine-bupivacaine-vs-morphine-alone-for-analgesia-after-arthroscopy

Zitat kopieren
Bitte melden Sie sich an, um diese Funktion zu aktivieren

Um auf diese Funktion zugreifen zu können, müssen Sie bei einem aktiven OrthoEvidence-Konto angemeldet sein. Bitte melden Sie sich an oder erstellen Sie ein KOSTENLOSES Testkonto.

Premium-Mitglied-Funktion

Um auf diese Funktion zugreifen zu können, müssen Sie bei einem Premium-Konto von OrthoEvidence angemeldet sein.

Teilen Sie dies ACE Report